Search | IOVS | ARVO Journals

Showing 1 – 20 of 25

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

PROTEOMICS PROFILING OF DESCEMET MEMBRANES IN FUCHS ENDOTHELIAL CORNEAL DYSTROPHY

Viridiana Kocaba; Xiao Yu Ng; Dawn Neo Jing Hui; Vidhya Venkatraman Anandalakshmi; Gary S L Peh; Jodhbir S Mehta

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5804.

ARVO Annual Meeting Abstract June 2021

Modulation of In-vitro aggregation properties of TGFBIp peptides by osmolytes and toxicity of disaggregated amyloid fibrils

Anandalakshmi Venkatraman; Rajamani Lakshminarayanan; Jodhbir S Mehta

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):723.

ARVO Annual Meeting Abstract June 2020

IN SILICO COMPARISON OF RHO-KINASE INHIBITORS - PROTEIN DOCKING AFFINITY

Francisco Bandeira; Yossa Dwi Hartono; Anandalakshmi Venkatraman; José Álvaro Pereira Gomes; Gary S L Peh; Jodhbir S Mehta

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1465.

ARVO Annual Meeting Abstract July 2019

Matrix-Assisted Laser Desorption Ionization (MALDI) Mass Spectrometry Imaging (MSI) of key proteins in corneal samples from Lattice dystrophy patients with TGFBI - H626R and R124C mutation

Anandalakshmi Venkatraman; Jodhbir S Mehta

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5116.

ARVO Annual Meeting Abstract April 2014

Expression and characterization of the proline mutants in the 4th FAS1 domains of TGFβIP associated stromal corneal dystrophies

Elavazhagan Murugan; Rajamani Lakshminarayanan; Anandalakshmi Venkatraman; Victoria Mouvet; Roger W Beuerman; Jodhbir S Mehta

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1014.

Cornea June 2012

Depletion of SLC4A11 Causes Cell Death by Apoptosis in an Immortalized Human Corneal Endothelial Cell Line

PDF

Jun Liu; Li-Fong Seet; Li Wei Koh; Anandalakshmi Venkatraman; Divya Venkataraman; Rajiv R. Mohan; Jeppe Praetorius; Joseph A. Bonanno; Tin Aung; Eranga N. Vithana
TAGS: apoptosis, cell death, cornea, endothelial cells, polymerase chain reaction, genes
Invest. Ophthalmol. Vis. Sci.. 2012; 53(7):3270-3279. https://doi.org/10.1167/iovs.11-8724

ARVO Annual Meeting Abstract April 2009

Association of LOXL1 Gene Polymorphisms in Chinese Patients With Pseudoexfoliation Syndrome

D. Pek; E. N. Vithana; A. Thalamuthu; S. Ho; A. Venkatraman; D. Venkataraman; T. Aung

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):866.

ARVO Annual Meeting Abstract April 2009

Analysis of the Effects of SLC4A11 (CHED2) Gene Depletion on Corneal Endothelial Cell Growth and Proliferation

E. N. Vithana; A. Venkatraman; L. Koh; R. R. Mohan; L. Seet

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):1799.

Glaucoma September 2008

Association of LOXL1 Gene Polymorphisms with Pseudoexfoliation in the Japanese

PDF

Mineo Ozaki; Kelvin Y. C. Lee; Eranga N. Vithana; Victor H. Yong; Anbupalam Thalamuthu; Takanori Mizoguchi; Anandalakshmi Venkatraman; Tin Aung
TAGS: genes, japanese, polymorphism, single nucleotide polymorphism, alleles
Invest. Ophthalmol. Vis. Sci.. 2008; 49(9):3976-3980. https://doi.org/10.1167/iovs.08-1805

ARVO Annual Meeting Abstract May 2008

Association of LOXL1 Gene with Pseudoexfoliation in the Japanese

M. Ozaki; K. Y. Lee; T. Mizoguchi; V. H. Yong; A. Venkatraman; A. Thalamuthu; E. N. Vithana; T. Aung

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):5865.

ARVO Annual Meeting Abstract May 2008

Identification of a Novel UBIAD1 Mutation in a Chinese Family With Schnyder Crystalline Corneal Dystrophy (SCCD)

E. N. Vithana; J. S. Mehta; D. Venkataraman; A. Venkatraman; V. H. K. Yong; T. Aung; D. T. H. Tan

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):1007.

ARVO Annual Meeting Abstract May 2006

Glucocorticoid Receptor Polymorphisms and Corticosteroid–Induced Glaucoma

S.G. Schwartz; S. Gerzenstein; J. Ayala–Haedo; M. Polk; A.S. Venkatraman; C.A. Puliafito; M.E. Fini

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):205.

ARVO Annual Meeting Abstract May 2006

The Effects of Cataract Extraction on the Matrix Visual Field of Normal Eyes

N. Sekhon; A.S. Venkatraman; J. McSoley; D.L. Budenz; D.R. Anderson

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):664.

ARVO Annual Meeting Abstract May 2006

Optical Coherence Tomography Findings in a Variable–Dosing Regimen with Ranibizumab (LucentisTM): The PrONTO Study

G. Lalwani; A.E. Fung; S. Michels; A.S. Venkatraman; C.A. Puliafito; P.J. Rosenfeld

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):2147.

ARVO Annual Meeting Abstract May 2006

Visual Acuity Outcomes Following a Variable–Dosing Regimen for Ranibizumab (LucentisTM) in Neovascular AMD: The PrONTO Study

P.J. Rosenfeld; A.E. Fung; G.A. Lalwani; S. Michels; A.S. Venkatraman; C.A. Puliafito

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):2958.

ARVO Annual Meeting Abstract May 2006

Pars Plana Vitrectomy With Internal Limiting Membrane Peeling For Diabetic Macular Edema

K.L. Hartley; W.E. Smiddy; H.W. Flynn, Jr.; T.G. Murray; I. Voo; A.S. Venkatraman

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):3866.

ARVO Annual Meeting Abstract May 2005

Is It Safe to Get Sick in July?

K.L. Hartley; S.J. Gedde; A. Venkatraman

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):1959.

ARVO Annual Meeting Abstract May 2005

Optical Coherence Tomography (OCT) Outcomes Following Systemic Bevacizumab (Avastin®) Therapy for Neovascular Age–Related Macular Degeneration

C.A. Puliafito; P.J. Rosenfeld; S. Michels; A.A. Moshfeghi; A.E. Fung; K.D. Rosenberg; A.S. Venkatraman

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):1376.

ARVO Annual Meeting Abstract May 2005

Safety of Systemic Bevacizumab (Avastin®) Therapy for Neovascular Age–Related Macular Degeneration

S.M. Michels; P.J. Rosenfeld; C.A. Puliafito; A.A. Moshfeghi; A.E. Fung; K.D. Rosenberg; E.N. Marcus; A.S. Venkatraman

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):1378.

ARVO Annual Meeting Abstract May 2005

Durability of Systemic Bevacizumab (Avastin®) Therapy for Neovascular Age–Related Macular Degeneration

A.A. Moshfeghi; P.J. Rosenfeld; C.A. Puliafito; S. Michels; A.E. Fung; K.D. Rosenberg; A.S. Venkatraman

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):1381.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

PROTEOMICS PROFILING OF DESCEMET MEMBRANES IN FUCHS ENDOTHELIAL CORNEAL DYSTROPHY

Modulation of In-vitro aggregation properties of TGFBIp peptides by osmolytes and toxicity of disaggregated amyloid fibrils

IN SILICO COMPARISON OF RHO-KINASE INHIBITORS - PROTEIN DOCKING AFFINITY

Matrix-Assisted Laser Desorption Ionization (MALDI) Mass Spectrometry Imaging (MSI) of key proteins in corneal samples from Lattice dystrophy patients with TGFBI - H626R and R124C mutation

Expression and characterization of the proline mutants in the 4th FAS1 domains of TGFβIP associated stromal corneal dystrophies

Depletion of SLC4A11 Causes Cell Death by Apoptosis in an Immortalized Human Corneal Endothelial Cell Line

Association of LOXL1 Gene Polymorphisms in Chinese Patients With Pseudoexfoliation Syndrome

Analysis of the Effects of SLC4A11 (CHED2) Gene Depletion on Corneal Endothelial Cell Growth and Proliferation

Association of LOXL1 Gene Polymorphisms with Pseudoexfoliation in the Japanese

Association of LOXL1 Gene with Pseudoexfoliation in the Japanese

Identification of a Novel UBIAD1 Mutation in a Chinese Family With Schnyder Crystalline Corneal Dystrophy (SCCD)

Glucocorticoid Receptor Polymorphisms and Corticosteroid–Induced Glaucoma

The Effects of Cataract Extraction on the Matrix Visual Field of Normal Eyes

Optical Coherence Tomography Findings in a Variable–Dosing Regimen with Ranibizumab (LucentisTM): The PrONTO Study

Visual Acuity Outcomes Following a Variable–Dosing Regimen for Ranibizumab (LucentisTM) in Neovascular AMD: The PrONTO Study

Pars Plana Vitrectomy With Internal Limiting Membrane Peeling For Diabetic Macular Edema

Is It Safe to Get Sick in July?

Optical Coherence Tomography (OCT) Outcomes Following Systemic Bevacizumab (Avastin®) Therapy for Neovascular Age–Related Macular Degeneration

Safety of Systemic Bevacizumab (Avastin®) Therapy for Neovascular Age–Related Macular Degeneration

Durability of Systemic Bevacizumab (Avastin®) Therapy for Neovascular Age–Related Macular Degeneration

To View More...

You must be signed into an individual account to use this feature.